291 related articles for article (PubMed ID: 22305831)
1. Management of cardiac toxicity in patients receiving vascular endothelial growth factor signaling pathway inhibitors.
Steingart RM; Bakris GL; Chen HX; Chen MH; Force T; Ivy SP; Leier CV; Liu G; Lenihan D; Lindenfeld J; Maitland ML; Remick SC; Tang WH
Am Heart J; 2012 Feb; 163(2):156-63. PubMed ID: 22305831
[TBL] [Abstract][Full Text] [Related]
2. Initial assessment, surveillance, and management of blood pressure in patients receiving vascular endothelial growth factor signaling pathway inhibitors.
Maitland ML; Bakris GL; Black HR; Chen HX; Durand JB; Elliott WJ; Ivy SP; Leier CV; Lindenfeld J; Liu G; Remick SC; Steingart R; Tang WH;
J Natl Cancer Inst; 2010 May; 102(9):596-604. PubMed ID: 20351338
[TBL] [Abstract][Full Text] [Related]
3. Cardiovascular effects of systemic cancer treatment.
Senkus E; Jassem J
Cancer Treat Rev; 2011 Jun; 37(4):300-11. PubMed ID: 21126826
[TBL] [Abstract][Full Text] [Related]
4. Insights into cardiovascular side-effects of modern anticancer therapeutics.
Stortecky S; Suter TM
Curr Opin Oncol; 2010 Jul; 22(4):312-7. PubMed ID: 20535072
[TBL] [Abstract][Full Text] [Related]
5. Hypertension due to antiangiogenic cancer therapy with vascular endothelial growth factor inhibitors: understanding and managing a new syndrome.
Small HY; Montezano AC; Rios FJ; Savoia C; Touyz RM
Can J Cardiol; 2014 May; 30(5):534-43. PubMed ID: 24786444
[TBL] [Abstract][Full Text] [Related]
6. Cardiac testing to manage cardiovascular risk in cancer patients.
Davis M; Witteles RM
Semin Oncol; 2013 Apr; 40(2):147-55. PubMed ID: 23540740
[TBL] [Abstract][Full Text] [Related]
7. The emerging issue of cardiac dysfunction induced by antineoplastic angiogenesis inhibitors.
Tocchetti CG; Gallucci G; Coppola C; Piscopo G; Cipresso C; Maurea C; Giudice A; Iaffaioli RV; Arra C; Maurea N
Eur J Heart Fail; 2013 May; 15(5):482-9. PubMed ID: 23325019
[TBL] [Abstract][Full Text] [Related]
8. Strategies to prevent and treat cardiovascular risk in cancer patients.
Cardinale D; Bacchiani G; Beggiato M; Colombo A; Cipolla CM
Semin Oncol; 2013 Apr; 40(2):186-98. PubMed ID: 23540744
[TBL] [Abstract][Full Text] [Related]
9. [Modern therapy of cardiac insufficiency].
Stojsić D; Jelkić N
Med Pregl; 1999; 52(3-5):113-24. PubMed ID: 10518395
[TBL] [Abstract][Full Text] [Related]
10. API expert consensus document on management of ischemic heart disease.
Association of Physicians of India
J Assoc Physicians India; 2006 Jun; 54():469-80. PubMed ID: 16909697
[TBL] [Abstract][Full Text] [Related]
11. Cardiac toxicity from systemic cancer therapy: a comprehensive review.
Curigliano G; Mayer EL; Burstein HJ; Winer EP; Goldhirsch A
Prog Cardiovasc Dis; 2010; 53(2):94-104. PubMed ID: 20728696
[TBL] [Abstract][Full Text] [Related]
12. Cardiovascular toxicity associated with small molecule tyrosine kinase inhibitors currently in clinical use.
Dasanu CA; Padmanabhan P; Clark BA; Do C
Expert Opin Drug Saf; 2012 May; 11(3):445-57. PubMed ID: 22469002
[TBL] [Abstract][Full Text] [Related]
13. Targeted therapies: a new generation of cancer treatments.
Gerber DE
Am Fam Physician; 2008 Feb; 77(3):311-9. PubMed ID: 18297955
[TBL] [Abstract][Full Text] [Related]
14. Cardiovascular complications of cancer therapy: incidence, pathogenesis, diagnosis, and management.
Yeh ET; Bickford CL
J Am Coll Cardiol; 2009 Jun; 53(24):2231-47. PubMed ID: 19520246
[TBL] [Abstract][Full Text] [Related]
15. Therapy insight: Management of cardiovascular disease in patients with cancer and cardiac complications of cancer therapy.
Khakoo AY; Yeh ET
Nat Clin Pract Oncol; 2008 Nov; 5(11):655-67. PubMed ID: 18797437
[TBL] [Abstract][Full Text] [Related]
16. Predicting and preventing the cardiotoxicity of cancer therapy.
Anderson B; Sawyer DB
Expert Rev Cardiovasc Ther; 2008 Aug; 6(7):1023-33. PubMed ID: 18666852
[TBL] [Abstract][Full Text] [Related]
17. PI3K inhibitors as novel cancer therapies: implications for cardiovascular medicine.
McLean BA; Zhabyeyev P; Pituskin E; Paterson I; Haykowsky MJ; Oudit GY
J Card Fail; 2013 Apr; 19(4):268-82. PubMed ID: 23582093
[TBL] [Abstract][Full Text] [Related]
18. Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone).
Pergolizzi J; Böger RH; Budd K; Dahan A; Erdine S; Hans G; Kress HG; Langford R; Likar R; Raffa RB; Sacerdote P
Pain Pract; 2008; 8(4):287-313. PubMed ID: 18503626
[TBL] [Abstract][Full Text] [Related]
19. Cardiovascular toxicity of biologic agents for cancer therapy.
Bhave M; Akhter N; Rosen ST
Oncology (Williston Park); 2014 Jun; 28(6):482-90. PubMed ID: 25134321
[TBL] [Abstract][Full Text] [Related]
20. Use of Antihypertensive Drugs in Neoplastic Patients.
Rizzoni D; De Ciuceis C; Porteri E; Agabiti-Rosei C; Agabiti-Rosei E
High Blood Press Cardiovasc Prev; 2017 Jun; 24(2):127-132. PubMed ID: 28361339
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
